 Delayed-Action Preparations
"Delayed-Action Preparations" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Dosage forms of a drug that act over a period of time by controlled-release processes or technology.
| Descriptor ID |
D003692
|
| MeSH Number(s) |
D26.255.210 E02.319.300.253
|
| Concept/Terms |
Controlled-Release Preparations- Controlled-Release Preparations
- Controlled Release Preparations
- Controlled-Release Preparation
- Controlled-Release Formulations
- Controlled Release Formulations
- Controlled-Release Formulation
Sustained-Release Preparations- Sustained-Release Preparations
- Sustained-Release Preparation
- Extended Release Preparations
- Extended Release Preparation
- Slow Release Formulation
- Sustained Release Formulations
- Sustained Release Formulation
- Extended Release Formulations
- Extended Release Formulation
|
Below are MeSH descriptors whose meaning is more general than "Delayed-Action Preparations".
Below are MeSH descriptors whose meaning is more specific than "Delayed-Action Preparations".
This graph shows the total number of publications written about "Delayed-Action Preparations" by people in this website by year, and whether "Delayed-Action Preparations" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 | | 1997 | 0 | 1 | 1 | | 1999 | 1 | 2 | 3 | | 2000 | 0 | 2 | 2 | | 2002 | 1 | 4 | 5 | | 2003 | 1 | 2 | 3 | | 2005 | 1 | 5 | 6 | | 2006 | 2 | 2 | 4 | | 2007 | 0 | 7 | 7 | | 2008 | 0 | 4 | 4 | | 2010 | 0 | 3 | 3 | | 2011 | 2 | 6 | 8 | | 2012 | 2 | 5 | 7 | | 2013 | 2 | 9 | 11 | | 2014 | 0 | 7 | 7 | | 2015 | 2 | 6 | 8 | | 2016 | 3 | 6 | 9 | | 2017 | 0 | 7 | 7 | | 2018 | 4 | 6 | 10 | | 2019 | 0 | 3 | 3 | | 2020 | 1 | 7 | 8 | | 2021 | 0 | 2 | 2 | | 2022 | 0 | 2 | 2 | | 2023 | 0 | 3 | 3 | | 2024 | 4 | 5 | 9 | | 2025 | 0 | 5 | 5 | | 2026 | 0 | 5 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Delayed-Action Preparations" by people in Profiles.
-
Dunbar A, Rakhmanina N, Unternaher J, Anderson PL, Brooks KM. Long-Acting Injectable Antiretroviral Therapies for HIV Treatment and Prevention: Clinical Pharmacology, Recent Advances and Future Opportunities. J Clin Pharmacol. 2026 Aug; 66(8):e70249.
-
Sharp EE, Laforest L, Zhang Y, Xu KL, Cheng Z, Burdick JA, Gullbrand SE, Mauck RL. Streptavidin functionalized hyaluronic acid hydrogels for controlled and customizable drug delivery. Acta Biomater. 2026 Sep; 221:77-86.
-
Hsu HE, Lodi S, Yan S, Bovell-Ammon BJ, Christine PJ, Tilhou AS, Bernson D, Novo P, Lee JD, Rotrosen J, Liebschutz JM, Walley AY, Larochelle MR. Buprenorphine-Naloxone vs Extended-Release Naltrexone Following Opioid Withdrawal Treatment. JAMA Netw Open. 2026 Jul 01; 9(7):e2623280.
-
Escobedo HD, Schurr MJ, Nair DP. Nanogels for the targeted delivery of antibiotic and antimicrobial drugs. Ther Deliv. 2026 Feb; 17(2):125-138.
-
Alabi A, Kerr JS, Shah M, Khan A, Ma JD, Suhandynata RT, Momper JD, Tsunoda SM. Assessment of the Intestinal CYP3A Contribution to Drug Interactions with Extended-Release Tacrolimus (LCPT) Using Grapefruit Juice. Clin Pharmacol Drug Dev. 2026 01; 15(1):e70016.
-
Bommanahalli Nagaraju K, Dey A, Kompella U, Chauhan A. Pharmacokinetic model for drug delivery by Ozurdex. Drug Deliv Transl Res. 2026 04; 16(4):1249-1261.
-
Alabi A, Ge M, Momper JD, Tsunoda SM, Kelner MJ, Fitzgerald RL, Suhandynata RT. Measurement of Whole Blood Tacrolimus Concentrations by LC-MS/MS and Immunoassay Methods: Influence of Immediate-Release vs Extended-Release Tacrolimus Formulations. J Appl Lab Med. 2025 May 02; 10(3):546-558.
-
Jewell JS, Rockhill KM, Burkett H, Black JC, Ellis MS, Dart R. Trends in XTAMPZA ER and other oxycodone misuse and abuse during COVID-19: A mosaic approach. J Opioid Manag. 2025 May-Jun; 21(3):249-259.
-
Lodi S, Yan S, Bovell-Ammon B, Christine PJ, Hsu HE, Bernson D, Novo P, Lee JD, Rotrosen J, Liebschutz JM, Walley AY, Larochelle MR. Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone on treatment interruption: Comparing findings from a reanalysis of the X:BOT RCT and harmonized target trial emulation using population-based observational data. Addiction. 2025 Aug; 120(8):1634-1645.
-
Li J, Patel SK, Sweeney Y, Patton D, Anderson P, Hillier SL, Rohan LC. Engineering vaginal film platform for mucoadhesion and sustained drug release for HIV-1 prevention. J Control Release. 2025 03 10; 379:696-707.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|